IGM Biosciences, Inc. (NASDAQ:IGMS) Given Average Recommendation of “Reduce” by Brokerages
IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) has been given a consensus rating of “Reduce” by the ten brokerages that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating and nine have issued a hold rating on the company. The average twelve-month price objective […]
IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) has been given a consensus rating of “Reduce” by the ten brokerages that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating and nine have issued a hold rating on the company. The average twelve-month price objective […]
